Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-20

Clinical Trial Update: Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating metformin as add-on therapy to improve glycemic control in Type 1 Diabetes; current status is listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Type 1 Diabetes Mellitus, Metformin | Phase 4 | Status: UNKNOWN